Investigating the Effect of At Home Thermal Therapy on Dry Eye Patients With Meibomian Gland Dysfunction
- Conditions
- Dry Eye DiseaseMeibomian Gland Dysfunction
- Interventions
- Device: Thermal therapy device
- Registration Number
- NCT03291704
- Lead Sponsor
- UMay Care Inc.
- Brief Summary
The purpose of this pilot study is to determine the feasibility of at home thermal therapy with a wireless, portable device, as an effective management of Meibomian Gland Dysfunction.
This will be done by assessing patients for improvement in symptoms and ocular oil gland function after 4 weeks of a daily thermal therapy application.
- Detailed Description
This study will be a non-randomized, open label study of subjects with documented MGD. All subjects will be sent home with a wireless, portable thermal therapy device and examined pre and post treatment period. Subjects will be asked to use the device at bedtime for 5 minutes daily for 4 weeks. After treatment subjects will be re-examined and measured for clinical and symptomatic change in their MGD as well as changes to their sleep quality and anxiety index. Subjects will also be followed after treatment has been completed.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 20
- Clinical diagnosis of MGD
- Minimum age 18 years
- History of ocular disease, trauma, surgery (other than refractive), orbital cancer
- 3 month history of ocular infection and/or ocular inflammation not associated with dry eye
- 3 month history of any active physician administered or prescription dry eye treatment
- Pregnant, potentially pregnant or nursing
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Thermal Therapy Thermal therapy device Heat application using at home thermal therapy device
- Primary Outcome Measures
Name Time Method Change in Non-Invasive Tear Film Break Up Time (NITFBUT) in Seconds Before and after 4 weeks of daily treatment Ocular surface analysis of tear film evaporation
- Secondary Outcome Measures
Name Time Method Change in Ocular Surface Disease Index (OSDI) Score Before and after 4 weeks of daily treatment Standardized symptom questionnaire
Meibum Expressibility Before and after 4 weeks of daily treatment Grade of Meibum oil expressibility from Meibomian Gland
Sleep Quality Before and after 4 weeks of daily treatment Pittsburg Sleep Quality Index (PSQI)
State Trait and Anxiety Before and after 4 weeks of daily treatment State-Trait Anxiety Index (STAI)